Pathos

About:

Pathos develops an AI-enabled drug discovery platform to reduce the medication development process.

Website: https://pathos.com

Description:

Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthrough therapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)pathos.com

Founders:

Ryan Fukushima

Number of Employees:

1-10

Last Funding Date:

2023-03-02

IPO Status:

Private

© 2024 MyAiNote.com